Healthcare costs and treatment patterns associated with glucagon-like peptide 1 receptor agonist use among patients with metabolic dysfunction-associated steatohepatitis
- DOI
- 10.57264/cer-2024-0223
- Published
- 2025-11
- Container
- Journal of Comparative Effectiveness Research
- Publisher
- Becaris Publishing Limited
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.57264/cer-2024-0223,
title = {Healthcare costs and treatment patterns associated with glucagon-like peptide 1 receptor agonist use among patients with metabolic dysfunction-associated steatohepatitis},
author = {Elliot B Tapper and Taylor Ryan and Ni Zeng and Renee Carter and Jessamine P Winer-Jones and Machaon Bonafede and Yestle Kim},
year = {2025},
journal = {Journal of Comparative Effectiveness Research},
doi = {10.57264/cer-2024-0223},
url = {https://doi.org/10.57264/cer-2024-0223}
}RIS
TY - JOUR TI - Healthcare costs and treatment patterns associated with glucagon-like peptide 1 receptor agonist use among patients with metabolic dysfunction-associated steatohepatitis AU - Elliot B Tapper AU - Taylor Ryan AU - Ni Zeng AU - Renee Carter AU - Jessamine P Winer-Jones AU - Machaon Bonafede AU - Yestle Kim PY - 2025 JO - Journal of Comparative Effectiveness Research DO - 10.57264/cer-2024-0223 UR - https://doi.org/10.57264/cer-2024-0223 ER -
APA
Tapper, E. B., Ryan, T., Zeng, N., Carter, R., Winer-Jones, J. P., Bonafede, M., & Kim, Y. (2025). Healthcare costs and treatment patterns associated with glucagon-like peptide 1 receptor agonist use among patients with metabolic dysfunction-associated steatohepatitis. Journal of Comparative Effectiveness Research. https://doi.org/10.57264/cer-2024-0223
Source records
- crossref · retrieved 2026-09-27T01:12:21.333Z